APM
COGT icon

Avidity Partners Management’s Cogent Biosciences COGT Stock Holding History

Avidity Partners Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-287,104
Closed -$2.24M – 73
2024
Q4 		$2.24M Sell
287,104
-713,896
-71% -$7.11M 0.22% 58
2024
Q3 		$10.8M Buy
1,001,000
+294
+0% +$2.86K 0.55% 58
2024
Q2 		$8.44M Buy
1,000,706
+555,000
+125% +$4.21M 0.36% 66
2024
Q1 		$3M Buy
+445,706
New +$2.76M 0.1% 84
2022
Q4 		– Sell
-1,357,700
Closed -$20.3M – 92
2022
Q3 		$20.3M Buy
+1,357,700
New +$18.6M 0.41% 53
2021
Q2 		– Sell
-417,710
Closed -$3.67M – 125
2021
Q1 		$3.67M Sell
417,710
-101,935
-20% -$981K 0.1% 89
2020
Q4 		$5.84M Buy
+519,645
New +$5.71M 0.19% 74

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Avidity Partners Management's COGT Position: Q1 2025 in Review

Avidity Partners Management sold out of Cogent Biosciences (COGT) in Q1 2025, closing a stake of 287,104 shares — an estimated $2.24M sold.

Avidity Partners Management first reported a position in COGT in Q4 2020 and held it in 7 quarters. The position peaked at $20.3M in Q3 2022. 186 funds tracked by Wall St. Rank hold COGT as of Q1 2025.

  • Avidity Partners Management reported no remaining Cogent Biosciences position as of Q1 2025 after selling out during the quarter.
  • Avidity Partners Management sold 287,104 Cogent Biosciences shares in Q1 2025, an estimated $2.24M.
  • Avidity Partners Management first reported a position in Cogent Biosciences in Q4 2020 and held it in 7 quarters.
  • Avidity Partners Management's Cogent Biosciences position peaked at $20.3M in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2025.

Based on Avidity Partners Management's 13F filing for Q1 2025, filed 15 May 2025.